vimarsana.com

Page 6 - உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVAX Initiative: 106,000 Pfizer jabs to arrive today

The first consignment of 106,000 doses of the Pfizer Covid-19 vaccine is expected to arrive today under the global vaccine-sharing initiative COVAX. "The vaccine jabs will arrive tomorrow [today] but we are yet to decide who will be inoculated with these," Md Shamsul Haque, a line director at the Directorate General of Health Services, told The Daily Star yesterday. Initially,

WHO seeks more data on China s CoronaVac COVID-19 vaccine

Geneva [Switzerland], May 27 (ANI): The World Health Organization (WHO) is seeking more data on China's Sinovac Biotech-made COVID-19 vaccine, named CoronaVac, as it weighs whether to authorise a second Chinese vaccine under international pressure to help distribute more shots.

Purchase of Sinopharm Vaccine: Price disclosure sparks confusion

Purchase of Sinopharm Vaccine: Price disclosure sparks confusion Pfizer vaccine gets nod for emergency use in Bangladesh Photo: Collected Staff Correspondent Staff Correspondent Confusion has arisen over the price of Sinopharm shots as the government closes in on the vaccine purchase from China in a desperate effort to keep the inoculation campaign rolling. In a meeting, the Cabinet Committee on Government Purchase yesterday approved a proposal for buying 1.5 crore doses of Sinopharm s Covid-19 vaccine, paving the way for the final agreement. Immediately after the meeting, chaired by Finance Minister AHM Mustafa Kamal, a Cabinet Division official told reporters at a briefing that they were purchasing the vaccine at $10 per dose.

Wise up! ⋆ TheVoiceBW

FRANCISTOWN SOUTH MP: Wynter Mmolotsi Francistown South’s Member of Parliament, Wynter Mmolotsi has advised Botswana to be wise and strategic in covid-19 vaccine procurement. Speaking during a visit by a parliamentary committee on tourism dialogue with local tour operators in Maun on Monday last week, Mmolotsi noted that although different vaccines have been manufactured and approved by WHO, Botswana should prioritise vaccines manufactured not only from her trading partners but also from countries with populations that spend money in Botswana for tourism purposes. “The challenge we are having is that we are using vaccines from everywhere. We have used Sinopharm from China for instance, but each region trusts its vaccine more than others. So we have to look at where the bulk of our tourism comes from, is it coming from the West or somewhere else? That should guide us on where to buy our vaccine. If it is the West let’s buy from the West, if it is China let’s buy from

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.